CSPC Innovation Pharmaceutical: Announcement on Investment and Construction of New Projects by Subsidiaries under Control
CSPC Innovation Pharmaceutical: Interim report disclosure prompt announcement for 2024.
CSPC Innovation Pharmaceutical: Announcement regarding the proposed change of registered capital and amendment of the company charter and application for industrial and commercial change registration.
CSPC Innovation Pharmaceutical: Notice Regarding the Holding of the Second Extraordinary Shareholders' Meeting in 2024.
CSPC Innovation Pharmaceutical: Summary Table of Non-Operating Funds Used and Other Related Fund Transactions for the First Half of 2024.
CSPC Innovation Pharmaceutical: Announcement regarding the temporary non-holding of a shareholder meeting to deliberate on matters related to this trade.
CSPC Innovation Pharmaceutical: Announcement on Completing the Registration of Legal Representative Commercial Change and Obtaining a New Business License
CSPC Innovation Pharmaceutical: Announcement Regarding the Holding Subsidiary Receiving Drug Clinical Trial Approval Notification
CSPC Innovation Pharmaceutical: Announcement regarding the holding subsidiary obtaining approval for US drug clinical trials.
CSPC Innovation Pharmaceutical: Announcement regarding the conditional approval of the drug marketing application obtained by the holding subsidiary.
CSPC Innovation Pharmaceutical: Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders
CSPC Innovation Pharmaceutical: Legal Opinion of Beijing Junzejun Law Firm on Witnessing the 2024 First Extraordinary General Meeting of Shareholders of Shiyao Innovative Pharmaceutical Co., Ltd.
New Novus: Notice on Convening the First Extraordinary General Meeting of Shareholders in 2024
New Novus: Announcement on Resignation of Directors and General Manager, By-election of Directors, and Change of General Manager
New Novus: Announcement on the proposed change of the company's legal representative, amendments to the “Articles of Association” and registration of industrial and commercial changes
New Novus: Prompt Announcement for Disclosure of Report for the First Quarter of 2024
New Novus: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
New Novus: Legal Opinion of Beijing Junzejun Law Firm on Witnessing the 2023 Annual General Meeting of Shareholders of Shiyao Innovative Pharmaceutical Co., Ltd.
New Novus: Announcement on the holding subsidiary obtaining a notice of approval for drug clinical trials
New Novus: Announcement on the fulfillment of the 2023 annual performance promise of CSPC Group Shengxue Glucose Co., Ltd.
No Data